Ihlenfeld To Chair Washington-Baltimore Drug Trafficking Board

In 2022, the units disrupted the sale of more than $100 million of drugs, including fentanyl and methamphetamine.

These pills were made to look like Oxycodone, but they're actually an illicit form of the potent painkiller fentanyl. A surge in police seizures of illicit fentanyl parallels a rise in overdose deaths.

U.S. Attorney William Ihlenfeld has been appointed chair of the Washington-Baltimore High Intensity Drug Trafficking Area (HIDTA) executive board.

That board supports 43 drug task forces in West Virginia, Virginia, Maryland and the District of Columbia. In addition to drug seizures, they also bolster treatment and prevention efforts.

In 2022, the units disrupted the sale of more than $100 million of drugs, including fentanyl and methamphetamine.

Ihlenfeld, the U.S. attorney for the northern district of West Virginia, said he’d work to strengthen the response to the threat of Mexican drug cartels.

Ihlenfeld previously served as chair of the Appalachian High Intensity Drug Trafficking Area. That includes parts of West Virginia, Virginia, Kentucky and Tennessee.

Author: Curtis Tate

Curtis is our Energy & Environment Reporter, based in Charleston. He has spent more than 17 years as a reporter and copy editor for Gannett, Dow Jones and McClatchy. He has written extensively about travel, transportation and Congress for USA TODAY, The Bergen Record, The Lexington Herald-Leader, The Wichita Eagle, The Belleville News-Democrat and The Sacramento Bee. You can reach him at ctate@wvpublic.org.

Exit mobile version